NASDAQ:RCKT

Rocket Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy RCKT

*Your capital is at risk

$3.11

-0.100 (-3.12%)

At Close: Jul 31, 2026

Rocket Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 73.02. In total, the insiders bought 7.75M and sold 517.25K RCKT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	73.02
● Buy	7.75M shares
● Sell	517.25K shares
58% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence May 26, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 73.02. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 24, 2025 Buy	Common Stock A-Award	Fong Peter Director	Director	23 333 Value: $77.5K
Sep 24, 2025 Buy	Common Stock J-Other	Fong Peter Insider	Other	0 Value: $0
Sep 24, 2025 Buy	Common Stock J-Other	Fong Peter Insider	Other	0 Value: $0
Sep 24, 2025 Buy	Common Stock A-Award	Fong Peter Director	Director	23 333 Value: $77.5K
Sep 24, 2025 Buy	Common Stock A-Award	Fong Peter Director	Director	30 000 Value: $99.6K
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 000 000 Value: $40.0M
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	59 000 Value: $1.05M
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	41 000 Value: $782.8K
Sep 19, 2025 Sell	Common Stock J-Other	Rtw Investments, Lp See Remarks	Director	59 000 Value: $183.2K
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $40
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $19
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $18
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $19
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $40
Sep 19, 2025 Sell	Equity Swap (obligation to buy) X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 Value: $18
Sep 19, 2025 Sell	Common Stock J-Other	Rtw Investments, Lp See Remarks	Director	59 000 Value: $183.2K
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	41 000 Value: $782.8K
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	59 000 Value: $1.05M
Sep 19, 2025 Buy	Common Stock X-InTheMoney	Rtw Investments, Lp See Remarks	Director	1 000 000 Value: $40.0M
Sep 15, 2025 Buy	Common Stock J-Other	Rizvi Syed Ali-aamir Insider	Other	0 Value: $0
Sep 15, 2025 Buy	Common Stock J-Other	Rizvi Syed Ali-aamir Insider	Other	0 Value: $0
Sep 08, 2025 Buy	Common Stock A-Award	Militello John See Remarks	Officer	40 000 Value: $130.4K
Sep 08, 2025 Buy	Common Stock A-Award	Wilson Martin General Counsel	Officer	150 000 Value: $489.0K
Sep 08, 2025 Buy	Common Stock A-Award	Schwartz Jonathan David See Remarks	Officer	80 000 Value: $260.8K
Sep 08, 2025 Buy	Common Stock A-Award	Wilson Martin General Counsel	Officer	150 000 Value: $489.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ROCKET PHARMACEUTICALS INC

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder ...

Read Full Profile Here